Bioscience Reports · 2015 · 19 citations · 33 references
Life SciencesGeneticsMolecular BiologyChromatin BiologyChromatin StructureEpigeneticsChromatinEpigenetic AlterationsGenomic ImprintingHistone ModificationsDna Methylation ReprogrammingGlobal Dna MethylationHistone Methylation At Lysine 9Histone Methyltransferase InhibitionHistone MethyltransferasesImprinted Gene RegulationInduced Pluripotent Stem CellsLysine Methyltransferase Activity
Histone H3 lysine 9 dimethylation (H3K9me2) hypermethylation is thought to be a major influential factor in cellular reprogramming, such as somatic cell nuclear transfer (SCNT) and induction of pluripotent stem cells (iPSCs). The diazepin-quinazolin-amine derivative (BIX-01294) specifically inhibits the activity of histone methyltransferase EHMT2 (euchromatic histone-lysine N-methyltransferase 2) and reduces H3K9me2 levels in cells. The imprinted gene small nuclear ribonucleoprotein N (Snrpn) is of particular interest because of its important biological functions. The objective of the present study was to investigate the effect of BIX-01294 on H3K9me2 levels and changes in Snrpn DNA methylation and histone H3K9me2 in mouse embryonic fibroblasts (MEFs). Results showed that 1.3 μM BIX-01294 markedly reduced global levels of H3K9me2 with almost no cellular toxicity. There was a significant decrease in H3K9me2 in promoter regions of the Snrpn gene after BIX-01294 treatment. A significant increase in methylation of the Snrpn differentially methylated region 1 (DMR1) and slightly decreased transcript levels of Snrpn were found in BIX-01294-treated MEFs. These results suggest that BIX-01294 may reduce global levels of H3K9me2 and affect epigenetic modifications of Snrpn in MEFs.
33
Single-Cell Dynamics of Genome-Nuclear Lamina Interactions
Jop Kind, Ludo Pagie, Havva Ortabozkoyun et al. · Cell · 2013 · 755 citations